Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 18:17:1.
doi: 10.1186/s12948-019-0104-4. eCollection 2019.

PPI adverse drugs reactions: a retrospective study

Marco Casciaro  1 , Michele Navarra  2 , Giuseppina Inferrera  3 , Marta Liotta  1 , Sebastiano Gangemi  1 , Paola Lucia Minciullo  1
Affiliations

PPI adverse drugs reactions: a retrospective study

Marco Casciaro et al. Clin Mol Allergy. .

Abstract

Proton pump inhibitors (PPIs) are drugs capable of blocking the gastric pump H,K-ATPase in order to inhibit gastric acid secretion. Omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole belong to PPIs category. Although PPIs have a good safety profile, allergic reactions to these molecules can occur. The real rate of hypersensitive reactions to PPIs is unknown. The aim of this retrospective study is to evaluate the rate of hypersensitive reactions to PPIs in patients admitted to our Unit between 2008 and 2013 with a history of drug hypersensitivity. From a database of 1229 patients (921 women, 308 men) with adverse drug reaction we extrapolated the data about PPI reactions. Twelve patients (10 female, 2 men) had a positive history for hypersensitive reaction to PPI. Pantoprazole was the most frequently PPI involved. Based on patient personal history in some cases we performed an oral challenge test for an alternative anti-acid drug and none of them had adverse reactions. According to our experience and according to the literature and pharmacovigilance reports, ADR caused by PPIs are ever increasing. Adverse reactions to these drugs are still under-reported; however, considering the frequency of their prescription worldwide, the risk of severe allergic events is low. Further studies are needed to provide clearer data on the real incidence and prevalence about this matter. This should be useful to help physician in choosing the molecule to prescribe and, in case of hypersensitivity, the alternative molecule to test, also considering the possible cross-reactivity.

Keywords: Adverse reaction; Allergy; Hypersensitivity; PPI; Proton pump inhibitors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Rate of PPIs ADR
Fig. 2
Fig. 2
Signs and  symptoms frequency
Fig. 3
Fig. 3
Alternative drugs tested
See this image and copyright information in PMC

References

    1. Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10(6):528–534. doi: 10.1007/s11894-008-0098-4. - DOI - PMC - PubMed
    1. Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, Ashida K, Ohara S, Kashiwagi H, Adachi K, Higuchi K, Miwa H, Fujimoto K, Kusano M, Hoshihara Y, Kawano T, Haruma K, Hongo M, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51(8):751–767. doi: 10.1007/s00535-016-1227-8. - DOI - PubMed
    1. Robinson M, Horn J. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. Drugs. 2003;63(24):2739–2754. doi: 10.2165/00003495-200363240-00004. - DOI - PubMed
    1. Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010;16(19):2323–2330. doi: 10.3748/wjg.v16.i19.2323. - DOI - PMC - PubMed
    1. Pirson F, Geubel A, Marot L. Late hypersensitivity to omeprazole and other proton pump inhibitors. Acta Clin Belg. 2012;67(4):301–303. - PubMed